Low Bone Density
0
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AmgenOpportunistic screening for low BMD
Innovation PharmaceuticalsStrontium L-lactate
Genovate BiotechnologySoy Isoflavone
Clinical Trials (3)
Total enrollment: 1,576 patients across 3 trials
Clinical Deployment and Validation of Rho
Start: Nov 2022Est. completion: Oct 20231,146 patients
N/ACompleted
Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults
Start: Mar 2017Est. completion: Jul 201710 patients
N/ACompleted
A Taiwan Isoflavone Multicenter Study (TIMS)
Start: Dec 2004Est. completion: Dec 2007420 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.